British Heart Foundation (BHF) Advanced Fellow in cardiovascular nanomedicine
University of Oxford
Oxford, England, United Kingdom
Dr. Tabish is a nanoscientist and BHF Fellow in Cardiovascular Medicine Division, Oxford University. Starting in March 2025, he will lead the 'Cardiac Energetics and Redox Nanomedicine' (CERN) group within the same division, supported by funding from the BHF and Wellcome Trust.
His research centers on creating graphene nanostructures for controlled delivery of therapeutics, addressing challenges in cardiovascular diseases e.g., myocardial ischemia-reperfusion injury and in-stent restenosis.
Disclosure information not submitted.
Mitochondria-targeted nitric oxide releasing graphene oxide for cardiovascular therapeutics
Thursday, July 17, 2025
6:08 PM – 6:19 PM EDT